These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7198471)
1. [Investigations on the general effects of tinofedrine on heart and blood circulation (author's transl)]. Stroman F; Thiemer K Arzneimittelforschung; 1981; 31(11):1892-902. PubMed ID: 7198471 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacological effect of tinofedrine on cerebral and peripheral hemodynamics in the dog (author's transl)]. Thiemer K; Stroman F; Szelenyi I; von Schlichtegroll A Arzneimittelforschung; 1978; 28(8):1343-54. PubMed ID: 582400 [TBL] [Abstract][Full Text] [Related]
3. [Effect of tinofedrine on oxygen, glucose and lactate metabolism in dogs and rats]. Thjemer K; Obermeier K Arzneimittelforschung; 1981; 31(4):693-700. PubMed ID: 7195717 [TBL] [Abstract][Full Text] [Related]
4. [The action of oxyfedrine on haemodynamics, inotropism and blood perfusion of the partially ischaemic myocardium after digoxin premedication. Studies on anaesthetized dogs (author's transl)]. Hahn N; Raqué B; Holst A; Henn I; von Randow H; Malotki D; Oehr P; Felix R Arzneimittelforschung; 1981; 31(3):410-4. PubMed ID: 7194664 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
8. [The influence of tinofedrine on cerebral energy metabolism in normotensive, hypotensive and hypoxemic rats after carotis ligation (author's transl)]. Obermeier K; Thiemer K; von Schlichtegroll A Arzneimittelforschung; 1978; 28(8):1354-60. PubMed ID: 582401 [TBL] [Abstract][Full Text] [Related]
9. Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. Hof RP; Hof A J Cardiovasc Pharmacol; 1984; 6(1):68-75. PubMed ID: 6199614 [TBL] [Abstract][Full Text] [Related]
10. [Effects of dopamine on coronary and systemic hemodynamics (including regional myocardial blood flow) and myocardial substrate metabolism under thalamonal-anesthesia in dogs (author's transl)]. Okazaki K; Saito T; Tomino T; Tonogai R; Tanaka Y; Sakata S Masui; 1979 Apr; 28(4):356-64. PubMed ID: 439377 [No Abstract] [Full Text] [Related]
11. [Pharmacologic effects in combined use of oxyfedrine and beta-acetyldiogoxin]. Stroman VF; Hempel R Arzneimittelforschung; 1975 Mar; 25(3):386-8. PubMed ID: 1174037 [TBL] [Abstract][Full Text] [Related]
12. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
13. [Effect of strophanthin in adrenergic blockade on the blood supply and work of the heart in acute coronary artery occlusion]. Sapozhkov AV; Verger DIa; Vakhrameev NIa Farmakol Toksikol; 1983; 46(1):42-5. PubMed ID: 6297963 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide. Hirohashi M; Takasuna K; Asano M; Ryokawa Y; Tamura K Arzneimittelforschung; 1993 May; 43(5):578-83. PubMed ID: 8329003 [TBL] [Abstract][Full Text] [Related]
15. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]. Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs. Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761 [TBL] [Abstract][Full Text] [Related]
18. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538 [TBL] [Abstract][Full Text] [Related]
19. [Methodology of hemodynamic study of a vasodilator drug (author's transl)]. Morgant C; Merillon JP; Motte G; Guiomard A; Gourgon R Anesth Analg (Paris); 1980; 37(9-10):561-6. PubMed ID: 7469072 [TBL] [Abstract][Full Text] [Related]